TY - JOUR
T1 - Prevention of nausea and vomiting following breast surgery
AU - Layeeque, Rakhshanda
AU - Siegel, Eric
AU - Kass, Rena
AU - Henry-Tillman, Ronda S.
AU - Colvert, Maureen
AU - Mancino, Anne
AU - Klimberg, V. Suzanne
N1 - Funding Information:
R.L. And R.K. are supported by the Susan G. Komen Breast Cancer Clinical Fellowship and by the Virginia Clinton Kelley / Fashion Footwear Association of New York Breast Cancer Research Fellowship.
Copyright:
Copyright 2008 Elsevier B.V., All rights reserved.
PY - 2006/6
Y1 - 2006/6
N2 - Background: The purpose of this study was to determine the rate of nausea and vomiting in women following breast surgery (PONV) under general anesthesia (GA), before and after the introduction of a standardized prophylactic anti-emetic (AE) regimen. Methods: We performed a retrospective review of eligible patients, between July 2001 and March 2003. Patients operated on before September 2002 had standard preoperative care (old cohort [OC]); patients operated on after September 2002 were treated prophylactically with oral dronabinol 5 mg and rectal prochlorperazine 25 mg (new cohort [NC]). Data were collected from hospital records regarding age, diagnosis, comorbid conditions, previous anesthesia history, anesthesia and operative details, episodes PONV, and use of AE. The rate and severity of PONV was calculated for both cohorts. Results: Two hundred forty-two patients were studied: 127 patients in the OC and 115 patients in the NC. The median age was 56 years (range 32 to 65). The rate of nausea and vomiting were significantly better in the patients treated prophylactically with dronabinol and prochlorperazine (59% vs. 15%, P < .0001 and 29% vs. 3%, P < .0001). Twenty patients in the OC were given some prophylactic AE treatment and 12 (60%) of them required further treatment; only 12 of 109 patients (11%) in the NC required further AE treatment (P < .0001). Conclusion: PONV is a significant problem in breast surgical patients. Preoperative treatment with dronabinol and prochlorperazine significantly reduced the number and severity of episodes of PONV.
AB - Background: The purpose of this study was to determine the rate of nausea and vomiting in women following breast surgery (PONV) under general anesthesia (GA), before and after the introduction of a standardized prophylactic anti-emetic (AE) regimen. Methods: We performed a retrospective review of eligible patients, between July 2001 and March 2003. Patients operated on before September 2002 had standard preoperative care (old cohort [OC]); patients operated on after September 2002 were treated prophylactically with oral dronabinol 5 mg and rectal prochlorperazine 25 mg (new cohort [NC]). Data were collected from hospital records regarding age, diagnosis, comorbid conditions, previous anesthesia history, anesthesia and operative details, episodes PONV, and use of AE. The rate and severity of PONV was calculated for both cohorts. Results: Two hundred forty-two patients were studied: 127 patients in the OC and 115 patients in the NC. The median age was 56 years (range 32 to 65). The rate of nausea and vomiting were significantly better in the patients treated prophylactically with dronabinol and prochlorperazine (59% vs. 15%, P < .0001 and 29% vs. 3%, P < .0001). Twenty patients in the OC were given some prophylactic AE treatment and 12 (60%) of them required further treatment; only 12 of 109 patients (11%) in the NC required further AE treatment (P < .0001). Conclusion: PONV is a significant problem in breast surgical patients. Preoperative treatment with dronabinol and prochlorperazine significantly reduced the number and severity of episodes of PONV.
KW - Ambulatory surgery
KW - Breast surgery
KW - Postoperative nausea and vomiting
UR - http://www.scopus.com/inward/record.url?scp=33646723051&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33646723051&partnerID=8YFLogxK
U2 - 10.1016/j.amjsurg.2005.07.040
DO - 10.1016/j.amjsurg.2005.07.040
M3 - Article
C2 - 16720146
AN - SCOPUS:33646723051
SN - 0002-9610
VL - 191
SP - 767
EP - 772
JO - American Journal of Surgery
JF - American Journal of Surgery
IS - 6
ER -